My major research interest is in radiation therapy for lymphomas, genitourinary cancers—including prostate cancer, bladder cancer and seminoma—and late effects of treatment, especially second cancers. Current research activities include study of image guided precision radiotherapy. I also have a long-standing interest in cancer classification with an emphasis on staging and prognostic factors. In addition, my current interests include the application of modern information and communication technologies in cancer control.
Mary K Gospodarowicz
A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer.
Radiother Oncol. 2004 Jan;70(1):37-44
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):750-7
Cancer. 2004 Jan 1;100(1):1-5
Recurrent prostate cancer following external beam radiotherapy: follow-up strategies and management.
Urol Clin North Am. 2003 Nov;30(4):751-63
Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1374-81
Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
J Clin Oncol. 2003 Nov 15;21(22):4157-64
Semin Surg Oncol. 2003;21(1):13-8
Semin Surg Oncol. 2003;21(1):8-12
JAMA. 2003 Jul 23;290(4):465-75
Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.
J Natl Cancer Inst. 2003 Jul 2;95(13):971-80
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Professor, Department of Radiation Oncology, University of Toronto
President, Union for International Cancer Control (UICC)